Annual Total Long Term Liabilities
N/A
December 1, 2024
Summary
- EW annual total long term liabilities is not available.
Performance
EW Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
N/A
December 1, 2024
Summary
- EW quarterly total long term liabilities is not available.
Performance
EW Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
EW Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
EW Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Edwards Lifesciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.42 B(+2.8%) |
| Jun 2024 | - | $1.38 B(-4.3%) |
| Mar 2024 | - | $1.44 B(-0.6%) |
| Dec 2023 | $1.45 B(-1.0%) | $1.45 B(+3.1%) |
| Sep 2023 | - | $1.40 B(+0.3%) |
| Jun 2023 | - | $1.40 B(-7.1%) |
| Mar 2023 | - | $1.51 B(+3.0%) |
| Dec 2022 | $1.46 B(-10.5%) | $1.46 B(-2.6%) |
| Sep 2022 | - | $1.50 B(-0.7%) |
| Jun 2022 | - | $1.51 B(-6.9%) |
| Mar 2022 | - | $1.63 B(-0.6%) |
| Dec 2021 | $1.63 B(-7.6%) | $1.63 B(-1.1%) |
| Sep 2021 | - | $1.65 B(+0.6%) |
| Jun 2021 | - | $1.64 B(-6.5%) |
| Mar 2021 | - | $1.76 B(-0.7%) |
| Dec 2020 | $1.77 B(+23.1%) | $1.77 B(+1.4%) |
| Sep 2020 | - | $1.74 B(+1.9%) |
| Jun 2020 | - | $1.71 B(+19.9%) |
| Mar 2020 | - | $1.43 B(-0.6%) |
| Dec 2019 | $1.44 B(+10.0%) | $1.44 B(+4.5%) |
| Sep 2019 | - | $1.38 B(-0.0%) |
| Jun 2019 | - | $1.38 B(+0.1%) |
| Mar 2019 | - | $1.38 B(+5.2%) |
| Dec 2018 | $1.31 B(+1.3%) | $1.31 B(-2.2%) |
| Sep 2018 | - | $1.34 B(-0.2%) |
| Jun 2018 | - | $1.34 B(+5.8%) |
| Mar 2018 | - | $1.26 B(-2.0%) |
| Dec 2017 | $1.29 B(-5.0%) | $1.29 B(-18.9%) |
| Sep 2017 | - | $1.59 B(-2.8%) |
| Jun 2017 | - | $1.64 B(+12.6%) |
| Mar 2017 | - | $1.45 B(+6.9%) |
| Dec 2016 | $1.36 B(+26.1%) | $1.36 B(+21.9%) |
| Sep 2016 | - | $1.11 B(+1.1%) |
| Jun 2016 | - | $1.10 B(+0.5%) |
| Mar 2016 | - | $1.10 B(+1.8%) |
| Dec 2015 | $1.08 B(+18.9%) | $1.08 B(+16.7%) |
| Sep 2015 | - | $922.70 M(+5.5%) |
| Jun 2015 | - | $874.50 M(+0.6%) |
| Mar 2015 | - | $869.20 M(-4.0%) |
| Dec 2014 | $905.50 M(+10.4%) | $905.50 M(+3.0%) |
| Sep 2014 | - | $878.80 M(+0.9%) |
| Jun 2014 | - | $871.20 M(-8.7%) |
| Mar 2014 | - | $954.70 M(+16.4%) |
| Dec 2013 | $819.90 M(+107.7%) | $819.90 M(+8.2%) |
| Sep 2013 | - | $758.10 M(+70.1%) |
| Jun 2013 | - | $445.70 M(+10.3%) |
| Mar 2013 | - | $404.20 M(+2.4%) |
| Dec 2012 | $394.80 M | $394.80 M(+9.4%) |
| Sep 2012 | - | $360.90 M(+1.3%) |
| Jun 2012 | - | $356.20 M(+2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $348.70 M(+13.4%) |
| Dec 2011 | $307.40 M(+153.6%) | $307.40 M(-5.8%) |
| Sep 2011 | - | $326.30 M(+7.4%) |
| Jun 2011 | - | $303.90 M(+137.2%) |
| Mar 2011 | - | $128.10 M(+5.7%) |
| Dec 2010 | $121.20 M(-27.5%) | $121.20 M(+10.5%) |
| Sep 2010 | - | $109.70 M(-60.3%) |
| Jun 2010 | - | $276.40 M(+31.2%) |
| Mar 2010 | - | $210.70 M(+26.1%) |
| Dec 2009 | $167.10 M(-36.4%) | $167.10 M(-22.4%) |
| Sep 2009 | - | $215.40 M(-0.7%) |
| Jun 2009 | - | $216.90 M(+0.7%) |
| Mar 2009 | - | $215.40 M(-18.1%) |
| Dec 2008 | $262.90 M(+95.2%) | $262.90 M(-5.0%) |
| Sep 2008 | - | $276.80 M(+23.4%) |
| Jun 2008 | - | $224.40 M(+59.0%) |
| Mar 2008 | - | $141.10 M(+4.8%) |
| Dec 2007 | $134.70 M(-50.3%) | $134.70 M(+6.0%) |
| Sep 2007 | - | $127.10 M(+5.3%) |
| Jun 2007 | - | $120.70 M(-57.6%) |
| Mar 2007 | - | $284.80 M(+5.0%) |
| Dec 2006 | $271.20 M(-21.4%) | $271.20 M(-4.8%) |
| Sep 2006 | - | $284.90 M(-8.2%) |
| Jun 2006 | - | $310.30 M(-2.7%) |
| Mar 2006 | - | $319.00 M(-7.5%) |
| Dec 2005 | $344.90 M(+19.3%) | $344.90 M(+22.7%) |
| Sep 2005 | - | $281.20 M(-5.9%) |
| Jun 2005 | - | $298.70 M(+0.0%) |
| Mar 2005 | - | $298.60 M(+3.3%) |
| Dec 2004 | $289.20 M(-3.3%) | $289.20 M(-4.3%) |
| Sep 2004 | - | $302.30 M(-13.0%) |
| Jun 2004 | - | $347.40 M(-7.9%) |
| Mar 2004 | - | $377.20 M(+26.1%) |
| Dec 2003 | $299.10 M(+4.0%) | $299.10 M(-6.6%) |
| Sep 2003 | - | $320.10 M(-4.3%) |
| Jun 2003 | - | $334.60 M(+10.3%) |
| Mar 2003 | - | $303.30 M(+5.4%) |
| Dec 2002 | $287.70 M(-15.3%) | $287.70 M(+1.1%) |
| Sep 2002 | - | $284.60 M(-10.4%) |
| Jun 2002 | - | $317.60 M(+2.0%) |
| Mar 2002 | - | $311.30 M(-8.3%) |
| Dec 2001 | $339.60 M(-20.8%) | $339.60 M(-12.8%) |
| Sep 2001 | - | $389.60 M(-0.7%) |
| Jun 2001 | - | $392.40 M(-4.3%) |
| Mar 2001 | - | $410.00 M(-4.4%) |
| Dec 2000 | $429.00 M(+652.6%) | $429.00 M(+6.2%) |
| Sep 2000 | - | $404.00 M(+6.0%) |
| Jun 2000 | - | $381.00 M(+4.1%) |
| Mar 2000 | - | $366.00 M |
| Dec 1999 | $57.00 M | - |
FAQ
- What is the all time high annual total long term liabilities for Edwards Lifesciences?
- What is the all time high quarterly long term liabilities for Edwards Lifesciences?
What is the all time high annual total long term liabilities for Edwards Lifesciences?
Edwards Lifesciences all-time high annual total long term liabilities is $1.77 B
What is the all time high quarterly long term liabilities for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly total long term liabilities is $1.77 B